Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Zimmer BioMet

Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Monday agreed to acquire Monogram Technologies Inc. (NASDAQ:MGRM) for an upfront payment of $4.04 per share, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million.

Benzinga

Zimmer Biomet Hits 34th 52-Week Low: Value Play or Value Trap?

Zimmer Biomet hit its 34th 52-week low on Tuesday. Its shares have decreased by over 20% in the past year. Trading at just 11.8x the 2025 EPS estimate, the maker of orthopedic medical devices looks cheap.

Barchart

Is Zimmer Biomet Stock Outperforming the S&P 500?

Zimmer Biomet has recently surged past the S&P 500 Index, with analysts maintaining a cautiously upbeat outlook on its growth potential.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

1 Stock to Buy ASAP to Cash in on the Pickleball Craze

As pickleball injuries rise, this medical device stock is perfectly positioned to cash in on the sport’s booming popularity.

Barchart

Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink?

Despite trailing the broader market over the past year, Zimmer Biomet still holds a moderately favorable outlook among analysts.

Barchart

How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks?

Zimmer Biomet Holdings has significantly underperformed other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Is Wall Street Bullish or Bearish on Zimmer Biomet Stock?

While Zimmer Biomet has lagged behind the broader market over the past year, analysts continue to hold a moderately positive view on the stock's prospects.

Barchart

Arnold Schwarzenegger, Zimmer Biomet’s first chief movement officer, wants older adults to stay active

The “Governator,” 77, is on a mission to spread the gospel of active aging.

Fortune

Here's What to Expect From Zimmer Biomet Holdings' Next Earnings Report

Zimmer Biomet Holdings is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings growth.

Barchart

Zimmer Biomet Stock: Is ZBH Underperforming the Healthcare Sector?

Zimmer Biomet has underperformed the healthcare sector over the past year, yet analysts remain moderately bullish about the stock’s prospects.

Barchart

Zimmer Biomet Hammered, Sales Expected To Take A Surprise 1% Hit

Zimmer Biomet stock tumbled Thursday after the medtech company said implementing a new enterprise system would slug 2024 sales by 1%.

Investors Business Daily

Are Wall Street Analysts Bullish on Zimmer Biomet Stock?

Despite Zimmer Biomet underperforming the broader market over the past year, analysts remain moderately bullish on the stock’s prospects.

Barchart

Earnings Preview: What to Expect From Zimmer Biomet’s Report

Zimmer Biomet will release its second-quarter earnings next month, and analysts anticipate a single-digit profit growth.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar

Dexcom stock surged Wednesday after the company allayed concerns that popular weight-loss drugs would tamp on its diabetes devices.

Birmingham Post

Ministers cannot be the last to know when inward investors like Zimmer Biomet pull out of Wales

A more constructive approach to managing relationships with major employers is important in the future especially if they are in receipt of public funding.

Wales Online

Deep concern as Zimmer Biomet closure in Bridgend puts 540 jobs at risk

The announcement has left a community in shock

Birmingham Post

Hundreds of jobs at threat at South Wales hip replacement factory

Zimmer Biomet has confirmed plans to close its factory in Bridgend

Get all your
news in one place.

100’s of premium titles.
One news app.

Wales Online

540 jobs at risk as Bridgend Zimmer Biomet plant set to close

Zimmer Biomet in Bridgend has entered into consultation with its staff

Investors Business Daily

Dow Jones Futures Fall: Market Rally Resilient After Fed Surprise; Tesla Ends Record Run

The market rally held up, for now, amid a Fed forecast of two more rate hikes. Tesla ended a big win streak. Medical product firms flashed buy signals.

Benzinga

Masimo's (MASI) Q2 Earnings Surpass Estimates, Margins Down

Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%.

Benzinga

SVB Leerink Maintains Outperform Rating for Zimmer Biomet Holdings: Here's What You Need To Know

SVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE:ZBH) and raise its price target from $135.00 to $140.00. Shares of Zimmer Biomet Holdings are trading up 0.82% over the last 24 hours, at $121.67 per share.

Benzinga

Zimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates

Zimmer Biomet Holdings Inc's (NYSE:ZBH) Q1 sales increased by 3.9% Y/Y to $1.66 billion (up 6.8% on a constant currency basis), beating the consensus of $1.59 billion. Adjusted EPS was $1.61, which came in above the consensus of $1.41 and $1.55 a year ago. "We are encouraged by the better than expected results…

Investors Business Daily

Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others

As supply chain constraints continue to squeeze health care stocks, one analyst suggested Monday to look for "ports in storms."

People

Jerome Powell

2,884 stories

Arnold Schwarzenegger

752 stories

Vijay Kumar

130 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.